Byotrol Share Discussion Threads

[brownson] 10/11/2017 10:06

Another of the regular "nose in the trough" option announcements.
The fact is, none of the options will ever be exercised as the share price only ever goes down.
Once again they seek to reward the abject failure of the management.
Personally, I wouldn't pay them living wage.

[milesy] 10/11/2017 09:50

Chimers - you seem to have a habit of posting on boards for shares you clearly have no affection for, here and MMX for example.

Isn't it time to find stocks in which you have a more positive interest rather than expending time and energy trying to dissuade others from doing likewise.

You stated elsewhere that you avoid acting emotionally, but I've yet to encounter you not spouting all manner of vitriol.

[chimers] 10/11/2017 09:07

Chimers3 Aug '17 - 11:45 - 2946 of 2989 0 0 Edit
Handy tip No 4768.....Why not wait until they are 1p then you can buy even more!! ?

[1gw] 10/11/2017 09:00

So some more for me at 3.6p, when the apparent spread was 3.5 to 3.75. I had no problem buying at this price but when I tried a sell I couldn't get a quote for just 20,000 shares, so feels like there's still a bit of stock for sale.

[1gw] 10/11/2017 08:20

As a new arrival to the share register I like the structure of those options awards.

[1gw] 09/11/2017 09:52

Bought some more there at 3.5p.

[shroder] 10/10/2017 13:22

Good to have you on-board GW, came across another mention of Actizone in Solvays May 17 presentation.

p9

[1gw] 10/10/2017 10:55

Having watched this for a long time, finally decided to take an initial position given it was on offer at (just) below the placing price.

[sharesoc] 01/10/2017 20:13

There is a detailed report on Byotrol's recent AGM which can be found in our members area here:

To access the report, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here:

Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the report (and reports on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here:

[shroder] 01/10/2017 17:05

Thanks for the AGM feedback, few snippets on LSE from another attendee.

I thought Solvay may do another Capital Market day this Sept but nothing as yet. Last years presentation mentioned Actizone (p18) as part of their technology portfolio section.

[gostevie63] 30/9/2017 21:43

Okay, now that it has been on the ShareSoc members' network for a few days, here is the text of my AGM Report that I posted there (with a few typos corrected). With hindsight I should have paid more attention to the part of the presentation concerning the product range, but as it was my first Byotrol meeting I was more interested in getting a broad-brush overview of the company and its management rather than specific product detail.
__________________________________________

Byotrol plc AGM 2017

On Friday 28th September 2017 I attended the AGM of Byotrol plc at the London offices of finnCap, a venue that will be familiar to some ShareSoc members as it previously hosted many of its London Company Seminars.

The company describes itself as ‘an expert developer of consumer and professional antimicrobial technologies and products’ and more details can be found on its website www.byotrol.co.uk .

All four Directors were present, as was Company Secretary Denise Keenan, who welcomed us into to the meeting room, where tea, coffee, biscuits and copies of the Annual Report and Notice of AGM were available. There were 17 people in the room in total and I would estimate that about seven or eight of us were private investors.

After a brief introduction by Chairman John Langlands, Chief Executive David Traynor gave his presentation. He has been at the helm since 2013 and said that he and others ‘bear the scars of the last four years’, when the company would appear to have led something of a hand-to-mouth existence on a shoestring. However, a successful fundraising earlier this year raised around £4 million, which Traynor said gives them the financial resources necessary to face the next phase of the company’s development with ‘confidence and firepower’.

In 2013 the company had 32 staff in total, of whom seven were tech staff. That total number has now reduced to 17 but the tech headcount remains unchanged on seven, which indicates what Byotrol’s priorities were over that period.

That has inevitably left them short in other areas and some of the new funds will be used to establish a new sales, marketing and PR team – this is a big priority for Traynor. As he put it: ‘The technology has been developed, now we need to deliver it’.

The company considers itself to be a ‘chemical technology company’ and the presentation identified three growth areas:

• Surface care (US)
• Surface care (Europe and the Rest of the World)
• Hand sanitisation

The presentation then gave details of some of Byotrol’s current products. The website ( describes them with more clarity than I could attempt in this brief report.

Traynor stressed that Byotrol’s ‘excellent science’ would enable it to achieve high margins in those areas.

A brief Q&A session was cordial and didn’t unveil anything new of significance – unless I missed anything of course.

Then it was down to the formal business and all six resolutions were passed without dissent on a show of hands and by very comfortable margins on proxy votes. Afterwards there was the opportunity to chat with the Directors and others present over coffee. I had a brief chat with David Traynor and a slightly longer one with Non-Executive Till Medinger.

Perhaps my overarching impression from the meeting is that, buoyed by the successful fundraising, the Directors are looking forward to an exciting time ahead for the company. To their credit, both Traynor in his presentation and Medinger when I spoke with him afterwards, didn’t resort to ramptastic hyperbole. It was a case of: We know what we need to do, we have the funds to enable us to do it, now it’s up to us to make sure we deliver.

I am a new shareholder in Byotrol, having taken a small stake in the placing, and this was my first opportunity to attend one of their presentations and meet the management. Having done so, I am very happy to hold that small stake and follow developments over the next year with interest.
______________________________________

Ends

[wisecat2] 30/9/2017 06:14

Stevie. Can we read your report please

[shroder] 29/9/2017 22:52

Cheers Stevie, is associate membership sufficient or do you need the full Monty for access?


Couple of bits of general interest:

______________________________________________________

Introducing the New American Red Cross Hand Sanitizer



______________________________________________________

Solvay appear to have a dedicated chap promoting Actizone

Regional Marketing Director for Novecare / Global Marketing Actizone & Emollients
Solvay

April 2017 – Present (6 months)São Paulo Area, Brazil

[timbo003] 28/9/2017 22:59

Thanks Steve, I will review my hand-written notes from the Sept 4th General meeting over the weekend to see if there is anything else that I could add which may be of interest.

[gostevie63] 28/9/2017 18:47

AGM report now posted. The link is here.



With apologies for any errors or significant omissions.

[gostevie63] 28/9/2017 12:07

I attended the AGM this morning.

All very cordial and uncontroversial. 17 people in the room, of whom I'd guess about 7 or 8 of us were private investors.

A clear and honest presentation from David Traynor, who emphasised that the challenge and priority now is to deliver sales. To this end he will be using some of the placing funds to build a sales and marketing team.

All resolutions passed without dissent on a show of hands, and comfortably on proxy votes.

Seems like an exciting time for the Company.

I'll endeavour to do a write-up for ShareSoc over the weekend.

[shroder] 06/9/2017 14:54

Register building nicely, Fidelity and Maven Cap now added, not sure about the form used 8.3?

[shroder] 06/9/2017 09:39

Not sure either, nice back stop though - very impressed with the Red Cross product stateside, new 'pen type' applicator too.

[timbo003] 06/9/2017 09:33

Shroder

Almost certainly yes.

I was at the meeting on Monday (brief notes to follow) and I asked the question. I think they said there should be 3 notifications, I don't know whether Amati counts as one or two.

Edit: I read the slightly confusing RNS announcements that the Amarti funds have 6.2% (not 12%) in total, although I may be wrong on that.

[shroder] 06/9/2017 09:29

Looks like just over 12% for Amati various funds, few more to declare?

[milesy] 01/9/2017 08:49

Forgotten your eloquence tablets again Chimers?